Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors

被引:34
作者
Kieffer-Renaux, V
Viguier, D
Raquin, MA
Laurent-Vannier, A
Habrand, JL
Dellatolas, G
Kalifa, C
Hartmann, O
Grill, J
机构
[1] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France
[2] Inst Gustave Roussy, Dept Radiotherapy, Villejuif, France
[3] INSERM, U472, Villejuif, France
[4] St Maurice Natl Hosp, St Maurice, France
关键词
cerebellum; ependymoma; intellectual quotient; medulloblastoma; neuropsychological studies; therapeutic schedule;
D O I
10.1002/pbc.20329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. To evaluate intellectual decline in children with posterior fossa (PF) tumors treated with different therapeutic protocols. Procedure. Forty children had a complete neuropsychological evaluation prospectively twice, at least 6 months year (y) after the end of their treatment. Patients were classified into four groups according to treatment schedules: Group 1 (n = 7) PF radiotherapy (PFRT) alone at 50 Gy; Group 2 (n = 13) reduced-dose cranio-spinal irradiation (CSI) at 25 Gy with a PF boost; Group 3 (n = 9) standard CSI at 35 Gy and a PF boost; and Group 4 (n = 11) high-dose chemotherapy with stem cell support followed by PFRT at 50 Gy. Results. At the first evaluation (mean interval since diagnosis 3.7 y), the mean Full Scale intellectual Quotient (FSIQ) was 80 (SD = 19). Only patients in Group I had a normal mean IQ score of 92 (SD = 14). At the second evaluation (mean interval since diagnosis 6.3 y), the mean FSIQ scores were significantly lower with a mean difference of 2.4 points, i.e., a yearly decline of one point. The magnitude of the FSIQ decline was positively correlated with the first IQ score (P = 0.0001) and inversely correlated with age at diagnosis (P = 0.0005). A FSIQ decline was observed in all treatment groups except Group 1 (P = 0.005). The differences in FSIQ observed initially between the four treatment groups persisted at the second evaluation. Conclusions. This study shows that FSIQ continues to decline more than 4 years after the diagnosis but this yearly decline seems to decrease with time from diagnosis. Therapeutic schedules influence the magnitude of this decline. Long-term follow-up into adulthood is necessary to effectively adapt patient rehabilitation.
引用
收藏
页码:814 / 819
页数:6
相关论文
共 33 条
[1]   PROSPECTIVE RANDOMIZED TRIAL OF CHEMOTHERAPY GIVEN BEFORE RADIOTHERAPY IN CHILDHOOD MEDULLOBLASTOMA - INTERNATIONAL-SOCIETY-OF-PEDIATRIC-ONCOLOGY (SIOP) AND THE (GERMAN)-SOCIETY-OF-PEDIATRIC-ONCOLOGY (GPO) - SIOP-II [J].
BAILEY, CC ;
GNEKOW, A ;
WELLEK, S ;
JONES, M ;
ROUND, C ;
BROWN, J ;
PHILLIPS, A ;
NEIDHARDT, MK .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 25 (03) :166-178
[2]   Neuropsychological sequelae of the treatment of children with medulloblastoma [J].
Dennis, M ;
Spiegler, BJ ;
Hetherington, CR ;
Greenberg, ML .
JOURNAL OF NEURO-ONCOLOGY, 1996, 29 (01) :91-101
[3]  
DOZ F, 2002, MED PEDIATR ONCOL, V39, P248
[4]   Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? [J].
DupuisGirod, S ;
Hartmann, O ;
Benhamou, E ;
Doz, F ;
Mechinaud, F ;
Bouffet, E ;
Coze, C ;
Kalifa, C .
JOURNAL OF NEURO-ONCOLOGY, 1996, 27 (01) :87-98
[5]   Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes [J].
Grill, J ;
Renaux, VK ;
Bulteau, C ;
Viguier, D ;
Levy-Piebois, C ;
Sainte-Rose, C ;
Dellatolas, G ;
Raquin, MA ;
Jambaqué, I ;
Kalifa, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :137-145
[6]   Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage [J].
Grill, J ;
Viguier, D ;
Kieffer, V ;
Bulteau, C ;
Sainte-Rose, C ;
Hartmann, O ;
Kalifa, C ;
Dellatolas, G .
JOURNAL OF NEUROSURGERY, 2004, 101 (02) :152-158
[7]   Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology [J].
Grill, J ;
Le Deley, MC ;
Gambarelli, D ;
Raquin, MA ;
Couanet, D ;
Pierre-Kahn, A ;
Habrand, JL ;
Doz, F ;
Frappaz, D ;
Gentet, JC ;
Edan, C ;
Chastagner, P ;
Kalifa, C .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1288-1296
[8]   INTELLECTUAL OUTCOME IN CHILDREN WITH MALIGNANT-TUMORS OF THE POSTERIOR-FOSSA - INFLUENCE OF THE FIELD OF IRRADIATION AND QUALITY OF SURGERY [J].
HOPPEHIRSCH, E ;
BRUNET, L ;
LAROUSSINIE, F ;
CINALLI, G ;
PIERREKAHN, A ;
RENIER, D ;
SAINTEROSE, C ;
HIRSCH, JF .
CHILDS NERVOUS SYSTEM, 1995, 11 (06) :340-345
[9]  
KAO GD, 1994, CANCER-AM CANCER SOC, V74, P965, DOI 10.1002/1097-0142(19940801)74:3<965::AID-CNCR2820740328>3.0.CO
[10]  
2-Z